E.g., 03/05/2021
E.g., 03/05/2021

bioMérieux receives FDA clearance for expanded pathogen identification capability on VITEK® MS

31 July, 2017

With more than 15,000 distinct strains, VITEK® MS provides the microbiology lab with the most comprehensive Mass Spectrometry database to improve clinical decision-making for infectious diseases 

bioMérieux receives FDA Clearance for BioFire’s FilmArray® Respiratory Panel 2 (RP2)

01 June, 2017

The FilmArray® RP2 reduces sample-to-result time to only 45 minutes while enhancing pathogen coverage and overall sensitivity

The FilmArray® Respiratory Panel 2 plus (RP2plus) gets CE marked

20 April, 2017

bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system

06 April, 2017

bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis

24 February, 2017

bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury

19 January, 2017

bioMérieux launches EMAG®, a new generation automated system for the extraction of DNA and RNA

10 November, 2016

FilmArray® Respiratory Panel EZ is CLIA waived by the FDA

11 October, 2016

bioMérieux enlarges its pathogen identification capability on VITEK® MS

06 July, 2016

With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients with elevated risk of mortality

01 July, 2016

Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients

Pioneering diagnostics